Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A9-DPC Therapy in Patients With Parkinson's Disease
NCT05887466Phase 2Completed
- Sponsor
- S.Biomedics
- Start
- May 2023
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TED-A9 in Parkinson's disease (PD), sponsored by S.Biomedics. Started May 2023; status: completed.
02
Drugs
TED-A9
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05887466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887466.